• Subscribe
  • Magazines
  • About
  • Contact
  • Advertise
Friday 19 September 2025
  • zh-hant 中文
  • ja 日本語
  • en English
IAG
Advertisement
  • Newsfeed
  • Mag Articles
  • Video
  • Opinion
  • Tags
  • Regional
    • Africa
    • Australia
    • Cambodia
    • China
    • CNMI
    • Europe
    • Hong Kong
    • India
    • Japan
    • Laos
    • Latin America
    • Malaysia
    • Macau
    • Nepal
    • New Zealand
    • North America
    • North Korea
    • Philippines
    • Russia
    • Singapore
    • South Korea
    • Sri Lanka
    • Thailand
    • UAE
    • Vietnam
  • Events
  • Contributors
  • SUBSCRIBE FREE
  • 中文
No Result
View All Result
IAG
  • Newsfeed
  • Mag Articles
  • Video
  • Opinion
  • Tags
  • Regional
    • Africa
    • Australia
    • Cambodia
    • China
    • CNMI
    • Europe
    • Hong Kong
    • India
    • Japan
    • Laos
    • Latin America
    • Malaysia
    • Macau
    • Nepal
    • New Zealand
    • North America
    • North Korea
    • Philippines
    • Russia
    • Singapore
    • South Korea
    • Sri Lanka
    • Thailand
    • UAE
    • Vietnam
  • Events
  • Contributors
  • SUBSCRIBE FREE
  • 中文
No Result
View All Result
IAG
No Result
View All Result

MUST: Funding equal to LESS THAN ONE SINGLE DAY of Macau’s 2019 casino GGR would be enough to develop, produce 30 million doses of COVID-19 vaccine candidate

Andrew W Scott and Ben Blaschke by Andrew W Scott and Ben Blaschke
Tue 4 Aug 2020 at 17:43
MUST: Funding equal to LESS THAN ONE SINGLE DAY of Macau’s 2019 casino GGR would be enough to develop, produce 30 million doses of COVID-19 vaccine candidate

Professor Zhang Kang explains how the team’s vaccine attacks the Receptor Binding Domain (RBD) of the virus protein rather than the whole spike.

83
SHARES
1.3k
VIEWS
Print Friendly, PDF & Email

Scientists responsible for developing what they describe as a hugely promising COVID-19 vaccine candidate say they can complete human trials and produce 30 million doses by January 2021 on less than a single day’s worth of Macau 2019 casino revenue.

The revelations came at a press conference at the Faculty of Medicine at Macau University of Science and Technology (MUST) on Tuesday. The press conference was led by Professor Zhang Kang in Macau, and Professor Manson Fok, Dean of the Faculty, who appeared from Hong Kong by video.

The vaccine, announced last week by a team comprising researchers from MUST, in collaboration with Hong Kong Polytechnic University (PolyU), is seen as a leading candidate for mass production after what the researchers describe as exceptional results during early clinical trials. In particular, it induced a “potent functional antibody response” in immunized mice, rabbits and monkeys with those antibodies subsequently neutralizing the virus during laboratory studies by effectively blocking it from binding with cells in the host.

According to key scientists involved, the candidate vaccine is now ready to enter Phase II and Phase III trials which, if all goes well, could see the first 30 million doses manufactured and ready for distribution by late January.

However, at the press conference, it was revealed the project was at risk of stalling over a shortfall in funding. Speaking of the world’s largest casino hub, Professor Fok estimated HK$600 million (US$77 million), equivalent to 77% of one day of Macau casino revenue based on 2019 GGR, or just two days’ worth of gaming taxes collected by the Macau SAR Government, would be needed to develop and produce 30 million doses of the vaccine.

Journalists at Tuesday’s press conference.

The team revealed it had been knocked back in February after applying to the Macau government for funding of just MOP$500,000 (US$62,500), with Professor Fok indicating the government had not been convinced at the time that development of a vaccine was a realistic goal.

According to the MUST team, the cost of the collaborative research, which has involved more than 100 scientists from Macau, Hong Kong and mainland China, is already in the “tens of millions of US dollars” – all of it sourced from the internal resources of eight institutions involved.

But the team is also adamant their vaccine ranks among the most effective, perhaps even the most effective, of the more than 150 vaccine candidates currently being studied globally.

“From a conceptual standpoint, we think this will be a highly effective vaccine with a very low level of side effects,” said Professor Zhang, one of the team’s leaders.

According to Zhang, the team’s vaccine stands out from most others because it only attacks the Receptor Binding Domain (RBD) of the protein rather than the whole protein spike, therefore creating more effective antibodies.

The vaccine is also a standout because it utilizes recombinant DNA, such as that already used in the HPV vaccine widely used to combat various forms of cancer and genital warts. The technology is already readily available and used in manufacturing facilities around the world.

L to R: Dean Fok appearing by video alongside Professor Zhang Kang.

Zhang said the team initiated development of its vaccine shortly after Chinese New Year, with Phase I testing showing no side effects. They are also encouraged by the fact that the vaccine requires administration of an extremely small dose – around 20 micrograms or 1/10th the size of a sesame seed.

Notably, Zhang says the vaccine should even be able to treat those already sick with COVID-19.

The team is now waiting to progress to the next step, Zhang said, where it plans to run Phase II and Phase III trials in humans concurrently to expedite the process.

“We are very confident from our results in the animal studies of its worth,” he said.

Fok added, “Normally human trials to deployment is one-and-a-half to two years,” but pointed to the fact that COVID-19 is not a normal situation. “So far the vaccine has shown strong antibody response, no complications, a significant half-life and it will be very cost effective.”

Macau University of Science and Technology.

Fok did, however, note the vaccine could not be produced locally due to the absence of a vaccine facility in Macau, and a lack of testing capacity in mainland China due to a number of other candidate vaccines being tested. Instead, the MUST team has agreed to conduct a pilot manufacturing program with a partner in Taiwan, which they say has the capability to produce at least 30 million doses in a matter of weeks.

As previously reported by IAG, 8 million of those would be reserved for the people of Macau and Hong Kong. The team, Fok claimed, wants to “produce a vaccine for all of humanity.

“This is a global problem and needs a global solution,” he said.

RelatedPosts

Macau GGR hits MOP$19.8 billion in August, up 6% month-on-month

Government figures indicate Macau’s gaming industry recorded US$17.9 billion surplus in 2024

Wed 17 Sep 2025 at 18:04
Melco’s Tokyo office raided by Public Prosecutor as Akimoto scandal deepens

Melco prices new notes offering at US$500 million

Wed 17 Sep 2025 at 06:16
The changing face of Macau

Melco to launch private hospital at Macau’s Studio City as part of 10-year non-gaming concession commitment

Wed 17 Sep 2025 at 05:06
The 2023 Asian Gaming Power 50: Ones to watch

Hong Kong Stock Exchange deems Andrew Lo unsuitable to be director of LET Group or Summit Ascent due to attempted Tigre de Cristal sale

Tue 16 Sep 2025 at 15:14
Load More
Tags: Chinacovid-19Hong KongHong Kong Polytechnic UniversityMacauMacau University of Science and TechnologyMUSTProfessor Manson FokProfessor Zhang KangVaccination
Share53Share4
Andrew W Scott and Ben Blaschke

Andrew W Scott and Ben Blaschke

A former sports journalist in Sydney, Australia, Ben has been Managing Editor of Inside Asian Gaming since early 2016. He played a leading role in developing and launching IAG Breakfast Briefing in April 2017 and oversees as well as being a key contributor to all of IAG’s editorial pursuits.

Born in Australia, Andrew is a gaming industry expert and media publisher, commentator and journalist who moved to Hong Kong in 2005 and then Macau in 2009, when he founded O MEDIA, one of Macau’s largest media companies and parent company of Inside Asian Gaming.

Current Issue

Editorial – Flipping the script

Editorial – Flipping the script

by Ben Blaschke
Thu 28 Aug 2025 at 12:30

This month represents an important milestone for Inside Asian Gaming as we launch IAG EXPO – an expansion of the...

Asia market roundup

Asia market roundup

by Ben Blaschke
Thu 28 Aug 2025 at 12:26

Inside Asian Gaming takes a deep dive into the state of Asia-Pacific’s key gaming markets: who’s hot, who’s not and...

Rewriting the rules

Rewriting the rules

by Newsdesk
Thu 28 Aug 2025 at 11:43

IAG EXPO, taking place at Newport World Resorts from 8 to 10 September, is not your usual trade show. IAG...

Test of character

Test of character

by Newsdesk
Thu 28 Aug 2025 at 11:28

Since its establishment in 1989, Gaming Laboratories International (GLI) has developed into the world’s most trusted name when it comes...

Evolution Asia
Evolution Asia
Aristocrat
GLI
Nustar
SABA
Mindslot
Solaire
Hann
Tecnet
NWR
NWR

Related Posts

ARIA executive Ayesha Molino to replace Corey Sanders as MGM Resorts COO

ARIA executive Ayesha Molino to replace Corey Sanders as MGM Resorts COO

by Newsdesk
Fri 19 Sep 2025 at 06:06

MGM Resorts International has appointed ARIA COO Ayesha Molino as its new Chief Operating Officer effective 1 January 2026, replacing the outgoing Corey Sanders. Gary Fritz, currently President of MGM Resorts International Interactive, will take on the role of Chief...

Philippines casino GGR up 630% quarter-on-quarter in 3Q20

Philippines remote gaming industry heading towards period of heavy consolidation

by Ben Blaschke
Fri 19 Sep 2025 at 01:26

The recent surge in Philippine online gaming licensees is likely to enter a period of contraction in the near future, with barely a third of those currently operational generating sufficient revenue to justify their existence. Tonet Quiogue, Partner and Head...

1xBet and Paris Saint-Germain extend partnership for three more seasons

1xBet and Paris Saint-Germain extend partnership for three more seasons

by Newsdesk
Thu 18 Sep 2025 at 22:18

Global betting company 1xBet has extended its partnership with Champions League champs Paris Saint-Germain, retaining its status as the club’s official partner for the next three seasons. The renewal was confirmed during the final day of the 2025 SBC Summit...

Industry lawyer: All hope not lost for Thailand’s deflated casino bill

Industry lawyer: All hope not lost for Thailand’s deflated casino bill

by Ben Blaschke
Thu 18 Sep 2025 at 20:04

Thailand’s controversial Entertainment Complex Bill may be dead in the water, but there remains some hope that it could yet be revived – possibly as soon as early 2026 – according to prominent industry lawyer Lau Kok Keng, Partner and...

Your browser does not support the video tag.


IAG

© 2005-2025
Inside Asian Gaming.
All rights reserved.

  • SUBSCRIBE FREE
  • NEWSFEED
  • MAG ARTICLES
  • VIDEO
  • OPINION
  • TAGS
  • REGIONAL
  • EVENTS
  • CONSULTING
  • CONTRIBUTORS
  • MAGAZINES
  • ABOUT
  • CONTACT
  • ADVERTISE
  • 中文

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • 中文
  • Subscribe
  • Newsfeed
  • Mag Articles
  • Video
  • Opinion
  • Tags
  • Regional
  • Events
  • Contributors
  • Magazines
  • Advertise
  • Contact
  • About
  • Home for G2E Asia

© 2005-2025
Inside Asian Gaming.
All rights reserved.

  • 中文
  • English